INCY

#599
Incyte Genomics Inc
97.33 USD
+1.86%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
97.31
97.72
Range Annuel
56.13
112.29
Changement quotidien
+1.86%
Changement Mensuel
+5.60%
Evolution sur 6 mois
+14.33%
Changement Annuel
+65.98%
Clôture Précédente
95.55
Open
97.61
Bid
Ask
Low
97.31
High
97.72
Volume
122
Open full chart

Financials

Overview Relevé Statistics
Quarterly Annual
  • Market Capitalization 19.37 B
  • Employee 2 844
  • Founded 2002
  • CEO Hervé Hoppenot
  • Website www.incyte.com
  • Headquarter Delaware, United States
  • FIGI BBG000BNPSQ9
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
15.41
Price to sales ratio
3.86

Incyte Corporation

Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia. Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity.

Nouvelles